| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 1.1K | 3.5% | 13.1% |
| Total Income | 1.1K | 3.8% | 13.1% |
| Expenditure | 1.1K | 2.9% | 10.3% |
| PBT | 49.50 | 21.2% | 164.4% |
| Net Profit | 41.22 | 6.9% | 410.0% |
| OPM | 9.42% | 0.33pp | 2.86pp |
| NPM | 3.63% | 0.12pp | 2.82pp |
| EPS | 5.63 | 6.9% | 411.8% |
13% growth masks seasonality, Africa weak, margins pressured
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
FY27 15%+ growth still guided but challenged by Q2 weakness (13%); BTPL margin target walked down from mid-to-high single digits to near-zero
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong consolidated growth (13% YoY) and EBITDA rise (48% YoY) are overshadowed by weak Africa seasonality, margin stagnation (OPM 9.4%), and execution risk. FY27 guidance of 15%+ growth is now contingent on strong H2 recovery. Capex expansion and BTPL integration add medium-term upside but near-term headwinds (tariffs, wage pressures) argue caution.
₹1112.8 Cr
Revenue · +13% YoY₹41.2 Cr
Reported PAT · +410% YoYFlat
Margins · vs guidance: MixedDid the claims hold up?
India business grew 10% YoY in seasonally weak Q2
METConsolidated grew 13% YoY; Africa 32% YoY implies India ~10%
Africa delivered 32% YoY growth, improved realizations
METAnnualized Africa ~₹250Cr; prior ₹190Cr = ~32% consistent
EBITDA rose 48% YoY; income grew 13% YoY
METOPM 9.4% vs ~6.3% prior implies 48% EBITDA growth; PAT 410% on low Q2FY26 base
FY27 consolidated growth 15%+ remains on track
OVERSTATEDQ2 at 13%; H2 must average 17%+ to hit 15%+ full year. Challenged by weak Africa Q2
Africa FY28 revenue ₹110-120M visibility strong
OVERSTATEDCurrent annualized ~₹250Cr ($30M). To hit $112-120M (₹930-1,000Cr) requires 4x growth. Aggressive
Earnings quality
What changed since the last call
BTPL EBITDA margin target diluted
DowngradePrior: mid-to-high single-digit EBITDA margin by Q4. New: PBT level breakeven (near-zero EBITDA). Q2 EBITDA slightly negative
Capex guidance raised
UpgradePrior: ₹70-75Cr for FY27 (₹100Cr total for Jharkhand/Karnataka). New: ₹150Cr FY27, ₹175Cr next year
Africa FY27 revenue tracking upward
UpgradePrior: $112-115M. Now: Management has visibility to $60M in Q3-Q4, plus prior Q1-Q2 suggests $120-130M run-rate
FY27 consolidated growth 15%+ maintained but challenged
NeutralQ2 showed only 13% growth; need 17%+ in H2 to hit 15%+ full year. No formal cut, but contingent on strong recovery
The Q&A
Analysts pressed hard on Africa customer concentration (20-25% from one customer), Bangladesh wage unrest, and low pre-booked volumes. Management downplayed risks, cited tariff clarity and long FTA ramp-up timelines. Few direct answers on BTPL legal issues; acknowledged but said procedures being followed. Overall, analysts were skeptical of near-term but not combative.
Labor skill shortage — Harshit Golecha, Flair Investments
AnsweredNo issue. Using migrant labor, training camps across central/eastern India, pipeline in place. No labor constraint.
Atraco margin seasonality — Jignesh Kamani, Nippon Mutual Fund
AnsweredSix months down the line, confident of 10% EBITDA margin at Atraco.
Realization sustainability — Soham Samanta, Motilal Oswal
AnsweredSustainable. Depends on product mix, targeting higher ASP, margin conscious; Q1-Q2 higher realizations due to outwear; Q3-Q4 seasonal variations but volume growth also strong.
Africa customer concentration — Vishal Mehta, IIFL Capital
PartialWant to de-risk gradually; secured two new customers for Kenya/Africa starting FY28. No immediate de-risking; customer is large Q2-H2 customer; will ramp down slowly.
Bangladesh wage unrest — Abhishek Shankar, ICICI Direct
PartialLDC status and low wages keep Bangladesh competitive. Wages up 50% over 3 years but Taka depreciating. Zero duty EU access expiring Nov 2029. Opportunity for India but Bangladesh will stabilize.
RoSCTL scheme benefit — Tushar Dhonde, Shangvi Family Office
AnsweredAbout 1.5% of export revenue dependent, 1.5% duty drawback. If cut to 50%, 0.75% impact absorbed in pricing and productivity.
India capacity utilization — Saurabh Srivastava, Arista Consulting
AnsweredIndia Q3: 92-93% utilization. Africa: 80-85% utilization, climbing up.
Capex plan and financing — Kumar Saurabh, Scientific Investing
AnsweredINR150Cr this year, ₹175Cr next. By FY 2029, aiming for INR4,000Cr capacity (3x current). Projections suggest ₹200Cr+ capex/year ahead. Funded from cash generation and debt optimization.
India apparel duty & FTA impact — Shirish Pardeshi, Motilal Oswal
PartialIndia-UK FTA effective July 2026 (1 year old); India-EU FTA expected soon; India has zero duty vs Bangladesh duty-free but wage advantage for India coming as FTA benefits flow. Bangladesh unrest real but not overblown.
Revenue capacity segment split — Niraj Mansing, White Pine Investment
AnsweredFY28: India ₹4,000Cr, Africa ₹1,250Cr, BTPL ₹1,200Cr. Total ₹6,450Cr capacity. BTPL 33% produced captively, rest netted off.
Billion-dollar revenue target — Gaurav Singh, Individual Investor
AnsweredBillion-dollar revenue in 4-5 years or more. No dividend imminent; waiting for tariff clarity and stability.
Guidance
FY27 consolidated +15%+ growth (mid-to-high teens)
MediumQ1-Q2 avg ~14%; H2 must avg ~17%+ to hit 15%+ full year. Africa seasonally strong H2, but macro/tariff headwinds present
Africa FY27 revenue $110-120M (₹910-1,000Cr)
MediumCurrent annualized ~$30M run-rate; Q3-Q4 visibility $60M implies ₹550-600Cr annualized FY27, tracking ₹910-1,000Cr if full year counted
FY28 consolidated growth double-digit + expected
MediumAssumes tariff stabilization, Africa recovery, BTPL normalization, Ranchi ramp-up. Orders in hand support 10%+ growth
India EBITDA margin 13% by FY28
MediumCurrent OPM 9.4%; targeting 13% via capex productivity, tariff pass-through, mix shift. Wage cost headwinds limit near-term
Africa (Atraco) EBITDA margin 10% by FY28
MediumQ2 weak at ~40% utilization; Q3-Q4 seasonal recovery should push 10%+. Customer de-risking and pricing power support
BTPL EBITDA margin 10% by FY28 (fabric business)
LowQ2-Q3 near-zero EBITDA; Q4 PBT breakeven; FY28 targeting 10% requires significant operational leverage. Margin visibility limited
FY27 capex ₹150Cr (Bhopal, Ranchi, brownfield)
HighBhopal phase 2 ramp-up, Ranchi 1,000-machine factory, brownfield debottlenecking. FY 2026-2029 total ₹450-500Cr
FY28 capex ₹175Cr; 2-3 factories to come online
MediumEach new factory ₹100-200Cr; annualized capex guidance ₹150-200Cr. Aimed at ₹4,000Cr revenue capacity by FY29
Risks the call surfaced
Guidance miss on FY27 growth
High15%+ growth guidance requires H2 to average 17%+ after weak Q2 (13%). Tariff pressures, macro softness, and customer deferrals could cause FY27 growth to fall short of 15%+
Africa customer concentration
MediumOne customer represents 20-25% of Africa revenue; customer is seasonal (Q2-H2 heavy). De-risking gradual; could impact volumes if customer defers orders or consolidates suppliers
BTPL integration and profitability
HighBTPL is loss-making (Q2 EBITDA slightly negative); legal challenges (Bombay Rayon investigation) pending; NCLT approval pending. Margin target diluted from mid-to-high single digits to near-zero by Q4. Integration complexity and customer overlap with Gokaldas could slow synergy realization
Tariff headwinds and pass-through risk
MediumUS tariff at 12.5% on India apparel is limiting pricing power and margin recovery. India apparel duty at 12.5% vs Bangladesh zero limits competitiveness. EU tariff changes and UK FTA ramp-up uncertain. Inability to pass through tariffs fully could compress margins
Bangladesh wage pressure and unrest
LowBangladesh wages up 50% over 3 years amid political unrest; LDC status expires Nov 2029 (extended to 2029). If unrest escalates or wage pressures accelerate, could force order shift to India/Vietnam, losing Bangladesh cost advantage. However, management is not over-dependent on Bangladesh capacity (most orders to India/Africa)
Management
Score 7/10. Clear on strategy (capex, market expansion, margin targets) but evasive on tougher topics (BTPL legal challenges, Bangladesh risk, dividend). Provided good operational detail (capacity, utilization, customer count). Some hedging on near-term guidance. Track record mixed. FY27 15%+ growth guidance now challenged by weak Q2 (13%); BTPL margin target walked down. Capex guidance raised from ₹100Cr to ₹150Cr suggesting faster-than-expected expansion needs. EBITDA growth (48% YoY) and debt reduction (₹124Cr improvement) show strong execution on profitability.
1 · Q3 FY27
Africa seasonal ramp-up, Bhopal capex commissioning, tariff pass-through
2 · Q4 FY27
BTPL PBT breakeven, India capacity additions, margin recovery expected
3 · FY28
Ranchi 1,000-machine factory ramp, Kenya/Europe orders begin shipping, double-digit growth
Capex expansion and BTPL integration add medium-term upside but near-term headwinds (tariffs, wage pressures) argue caution.
13% Growth Masks a Margin Squeeze Under Tariff Fire
Consolidated revenue grew 13% YoY and EBITDA surged 48%, but operating margins stalled while tariffs and wage costs ate into profit. The FY27 15%+ guidance now hinges on H2 recovery that has yet to arrive.
₹1,113 Cr
+13% YoY
+48%
YoY
9.4%
flat YoY, 1.3pp hedge-aided
₹41.2 Cr
-6.9% QoQ; low base distorts YoY
Gokaldas Exports delivered solid top-line growth (13% consolidated, Africa 32% YoY), and EBITDA expanded 48% year-on-year. But the bottom line tells a different story: profit fell 6.9% quarter-on-quarter despite revenue down only 3.5%, and margins stalled at 9.4% operating profitability — flat versus Q1. The culprit: tariff headwinds and wage cost inflation are compressing earnings faster than the company can pass them through to customers. Reported PAT of ₹41.2 Cr carries an asterisk: it's built on a weak Q2 FY26 base (tariff-hit last year), inflating the 410% YoY comparison.
The margin lie — growth that doesn't flow through
Here's the tension: 48% EBITDA growth but zero margin expansion. If EBITDA grew 48% but revenue grew only 13%, margins should have expanded 3+ points. They didn't. The reason: a 1.3 percentage point benefit from INR hedging masked an underlying margin decline. Back out that hedge gain, and Q2 operating margins would have been ~8.1%, down from Q1's 9.4%. Tariffs (US 12.5% on India apparel) and wage inflation in Bangladesh (up 50% over 3 years) are eating the upside. Africa 32% YoY growth is real, but it arrived at seasonally low 40% utilization and margin compression due to customer mix.
An inflationary environment with oil prices being high is creating a situation where Bangladesh workers tend to push for higher wages.
Net profit fell 6.9% quarter-on-quarter despite a modest revenue decline, confirming cost pressures are translating directly to the bottom line. Net profit margin compressed to 3.6% from a typical 5-7%, a warning flag that the business is struggling to absorb inflation without cutting volumes or accepting lower margins.
Management claims: what holds up, what doesn't
India business grew 10% YoY in seasonally weak Q2
Consolidated 13% + Africa 32% implies India ~10%
Supported
Africa delivered 32% YoY growth with improved realizations
Annualized ₹250–300 Cr (~₹190 Cr prior = 31–58% growth); utilization 40% (seasonal low)
Supported, but seasonality real
EBITDA rose 48% YoY
9.4% OPM vs ~6.3% prior = 48% growth ✓
Supported
FY27 consolidated growth 15%+ remains on track
Q2 at 13%; H2 needs 17%+ avg to hit 15%+ full year
Overstated — now challenged
Africa FY27 revenue guidance ₹500–650 Cr ($60–78M)
Current run-rate ~₹250 Cr ($30M); visibility to $60M Q3–Q4 suggests ₹550–650 Cr annualized
Tracking upward; contingent on seasonal ramp
What changed on this call
BTPL margin target walked down: From 'mid-to-high single-digit EBITDA margin by Q4' to 'PBT breakeven' (near zero). The Bombay Rayon textile assets acquired are proving harder to integrate; Q2 EBITDA was slightly negative. Management now targets Q4 revenue ₹250 Cr at PBT breakeven, with realistic 10% EBITDA margin by FY28 — a delay of 4+ quarters versus prior expectations. Legal challenges (Bombay Rayon investigation) are still pending but management expects clearance within 10 days.
Capex guidance raised: From ₹100 Cr (for FY27) to ₹150 Cr this year and ₹175 Cr next. This signals management's decision to accelerate factory buildouts (Bhopal phase 2, Ranchi 1,000-machine factory, brownfield debottlenecking) ahead of prior plan. The ambition is ₹4,000 Cr revenue capacity by FY29 (3x current), backed by structural capex of ₹150–200 Cr/year. The raise suggests prior guidance underestimated the pace needed to defend competitive position as Bangladesh wages rise and FTAs shift order flows.
Africa FY27 revenue guided upward: Prior range ₹500–650 Cr ($60–78M); current management commentary suggests full-year tracking ₹550–650 Cr if Q3–Q4 seasonal strength holds. New Kenya customers are starting FY28, adding modest revenue contribution and gradual de-risking of the 20–25% single-customer concentration.
Consolidated 13% growth in a weak quarter shows resilience
Africa 32% YoY growth breaking through tariff headwinds and seasonal weakness
Capex expansion and new factories (Ranchi, Bhopal) have concrete timelines and multi-year visibility
Net debt down ₹124 Cr YoY; deleveraging on track despite M&A
OPM flat at 9.4% despite 48% EBITDA growth signals margin pressure, not expansion
PAT down 6.9% QoQ despite modest revenue decline shows cost absorption without pricing power
FY27 15%+ growth now requires 17%+ H2 growth — unrealistic after weak Q2 (13%)
BTPL margin recovery delayed and legal challenges still pending
1.3pp hedge benefit masks underlying margin deterioration; Q3–Q4 reversal will be headwind
FY27 15%+ growth guidance requires 17%+ H2 growth; tariff/macro headwinds could force miss
HighQ2 delivered 13%; no formal cut yet, but contingency is real. Tariff clarity and retail demand softness are wildcards. Miss would break confidence in management's forecasting and trigger multiple compression.
Margin stagnation: OPM flat despite 48% EBITDA growth signals pricing-power loss
HighIf EBITDA grows but margins stay flat, the leverage is missing. Tariff pass-through is failing; cost inflation is winning. Without margin recovery to 10%+, 15%+ growth is mostly a volume story with limited profit leverage.
BTPL integration complexity: legal challenges (Bombay Rayon) and margin recovery slower than hoped
HighBTPL margin target cut from mid-single digits to near-zero by Q4. Q2 EBITDA slightly negative. If legal issues escalate or integration drags, BTPL becomes a drag on consolidated growth rather than a catalyst.
Africa customer concentration: 20–25% of revenue from one large customer; de-risking gradual
MediumOne customer is seasonal (Q2–H2 heavy, pre-summer). If this customer defers or consolidates suppliers, Africa growth stalls. De-risking (two new Kenya customers starting FY28) is phased over quarters.
Exchange hedge reversal: 1.3pp margin benefit in Q2 becomes headwind in Q3–Q4 as INR weakens to 93-94
MediumQ2 OPM 9.4% includes hedge gain; underlying was 8.1%. As hedge resets, margins face ~1.3pp headwind. Adds to tariff/wage pressure already in place. Q3–Q4 OPM could fall below 8%.
Bangladesh wage inflation and unrest: 50% wage rise over 3 years, LDC status expires Nov 2029
MediumBangladesh still competitive at current wages, but unrest risk is real. If escalates, could force order shift to India/Vietnam. India-UK/EU FTAs reduce Bangladesh dependency, but transition costs exist and timing is uncertain.
How the street is positioned
Price and trend: At ₹713.95, Gokaldas is trading 43.4% below its all-time high and 34.5% above its 52-week low. The stock sits above its SMA20 (₹681.78) and SMA50 (₹700.69) but below SMA200 (₹721.96), signaling a mild uptrend trapped in a drawn-down valuation zone. RSI at 55.2 is neutral — no oversold or overbought signal. Volume is normal. The market is cautious, not panicking, but not yet convinced of a rebound.
Ownership flows — the red flag: FII ownership has collapsed from 24.89% (Q1 FY26) to 13.42% (Q2 FY27), a drop of 11.5 percentage points. DII has stepped in, rising from 37.17% to 44.78% (+7.6pp). The narrative: foreign investors are exiting on execution risk (guidance contingency, margin pressure, tariff headwinds), and domestic money is adding at the discount. A bulk buy by SBI Life Insurance (4L shares @ ₹814.79 in June 2026) suggests some institutional confidence, but this is not enough to offset the FII exodus. The ownership rotation from FII to DII is a tell: skepticism on near-term guidance realization.
The reconciliation: Fundamentals align with price action and flows. This is not a "hated and cheap" opportunity — it's a "challenged execution" story where the market is right to be cautious. The drawdown is justified by margin pressure, guidance contingency, and FII skepticism. A rebound requires proof of: (1) H2 growth >17%, (2) OPM expansion to >10%, (3) BTPL breakeven confirmed, (4) tariff pass-through clarity. Until then, the stock should trade at a discount to history.
1 · Q3 FY27 revenue and margin (due ~January 2027)
The make-or-break metric. Must show >17% YoY growth to keep 15%+ FY27 guidance credible. OPM must expand to >10% (or >9.5% at minimum) as Africa seasonally ramps and BTPL absorbs fixed costs. If Q3 shows <15% growth or OPM <9%, FY27 guidance misses and re-rating is sharp downward.
2 · BTPL Q4 breakeven confirmation and PBT/EBITDA split
Management is targeting Q4 revenue ₹250 Cr at PBT breakeven (near-zero EBITDA). If materialized, it signals integration is on track and margin recovery for FY28 is achievable. If Q4 shows EBITDA still negative or PBT loss, integration risk escalates and FY28 guidance credibility suffers.
3 · FY28 India and Africa margin guidance (February 2027 concall)
Realism check. Management is guiding India 13% EBITDA margin and Africa 10% by FY28. If early commentary in Q4 results is cautious (lowered margins, extended timelines, reduced capex), it means Q3–Q4 margin recovery is fading and long-term targets are at risk.
Gokaldas Exports is executing a real long-term story — ₹4,000 Cr capacity, tariff-driven order shift to India, new geographies (Kenya). But Q2 FY27 revealed the near-term friction: margins are not expanding despite strong EBITDA growth, profit is decelerating quarter-on-quarter, and FY27 guidance is now contingent on a recovery that has yet to arrive. The company is not broken, but it is slowing — and the street's skepticism (FII exits, drawdown valuation, OPM stagnation) is warranted.
The number to track from here is operating margin. If OPM expands to 10%+ in H2 FY27 (despite the hedge reversal headwind), the thesis resets to 'recovery confirmed' and multiple re-rating follows. If OPM stays below 9%, the thesis becomes 'margin squeeze persists' and FY27 growth is mostly a volume story with no profit leverage — a disappointment that justifies the current drawdown. Hold — wait for H2 to show margin recovery before re-engaging.